Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Rocci

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
American Journal of Hematology|January 5, 2017
IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myelomaArnold Bolomsky, Wolfgang Hübl, Stefano Spada, et al.
Experimental Hematology|March 24, 2007
Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoirAlberto Rocci, Irene Ricca, Chiara Dellacasa, et al.
Experimental Hematology|September 10, 2003
Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma cloneMarco Ladetto, Barbara Mantoan, Irene Ricca, et al.
Proteomics|August 29, 2013
Characterization of multiple myeloma vesicles by label-free relative quantitationSean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Journal of Translational Medicine|December 13, 2012
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myelomaGiuseppina Bonanno, Andrea Mariotti, Annabella Procoli, et al.
Blood|February 28, 2004
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disordersMarco Ladetto, Mara Compagno, Irene Ricca, et al.
Cancer|December 19, 2018
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysisManuela Gambella, Paola Omedé, Stefano Spada, et al.
Experimental Hematology|December 13, 2006
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populationsMarco Ladetto, Barbara Mantoan, Federica De Marco, et al.
Cancer Cell|October 19, 2010
RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma developmentFlavia Pichiorri, Sung-Suk Suh, Alberto Rocci, et al.
Cancer Cell|October 28, 2022
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentFlavia Pichiorri, Sung-Suk Suh, Alberto Rocci, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
American Journal of Hematology|January 5, 2017
IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myelomaArnold Bolomsky, Wolfgang Hübl, Stefano Spada, et al.
Experimental Hematology|March 24, 2007
Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoirAlberto Rocci, Irene Ricca, Chiara Dellacasa, et al.
Experimental Hematology|September 10, 2003
Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma cloneMarco Ladetto, Barbara Mantoan, Irene Ricca, et al.
Proteomics|August 29, 2013
Characterization of multiple myeloma vesicles by label-free relative quantitationSean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Journal of Translational Medicine|December 13, 2012
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myelomaGiuseppina Bonanno, Andrea Mariotti, Annabella Procoli, et al.
Blood|February 28, 2004
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disordersMarco Ladetto, Mara Compagno, Irene Ricca, et al.
Cancer|December 19, 2018
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysisManuela Gambella, Paola Omedé, Stefano Spada, et al.
Experimental Hematology|December 13, 2006
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populationsMarco Ladetto, Barbara Mantoan, Federica De Marco, et al.
Cancer Cell|October 19, 2010
RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma developmentFlavia Pichiorri, Sung-Suk Suh, Alberto Rocci, et al.
Cancer Cell|October 28, 2022
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentFlavia Pichiorri, Sung-Suk Suh, Alberto Rocci, et al.
Pageof 4